Abstract:Background Patients with acute vertebrobasilar artery occlusion (VBAO) after endovascular treatment (EVT) frequently require mechanical ventilation (MV). This study aims to develop and validate a predictive score for prolonged mechanical ventilation (PMV) in patients with VBAO after EVT. Methods The derivation cohort prospectively recruited acute VBAO patients undergoing EVT from four comprehensive stroke centers (CSCs) in China. PMV was defined as continuous MV for ≥96 hours. Two multivariable logistic regressions were performed to predict predictive models based on whether adding radiographic results at follow-up. The performance of two models was evaluated for discrimination, calibration, and clinical utility. A validation cohort of 444 patients from acute Posterior circulation ischemic Stroke registry was enrolled to validate two models. Results The derivation cohort consisted of 498 patients from four CSCs, among whom 204 (41.0%) required PMV. Reperfusion status, National Institutes of Health Stroke Scale scores, collateral circulation status, history of atrial fibrillation, fasting blood glucose, circulation insufficiency, the presence of malignant cerebellar edema, and symptomatic intracranial hemorrhage at follow-up imaging were found to be independent predictors of PMV in multivariable logistic regression. These variables were combined to create the basic and radiographic PAIRS scores. The basic PAIRS and radiographic PAIRS scores demonstrated adequate discrimination in derivation cohort (C-index, 0.77 [95%CI 0.73 to 0.81] and 0.80 [95%CI 0.77 to 0.84]), as well as the validation cohort (C-index, 0.70 [95%CI 0.65 to 0.75] and 0.75 [95%CI 0.70 to 0.80]), and had well-fitted calibration plot for both cohorts. Decision curve analysis showed that both PAIRS scores had satisfied net benefit in predicting PMV across various thresholds. Conclusions The PAIRS scores provide adequate accurate predictions of PMV in VBAO patients after EVT. These findings can assist patient families and caregivers in better understanding the treatment trajectory. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial http://www.chictr.org.cn/; unique identifier: ChiCTR2000033211 ### Funding Statement This work was supported by Startup Fund for scientific research of Fujian Medical University (No XJ2021014001), Science and Technology Program of Guangzhou (No 202201020359), Key Research and Development Plan Projects of Anhui Province (No 202104j07020049). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by ethics committee of USTC: No 2020-40; Guangdong Second Provincial General Hospital: No 2020-KY-KZ-100-03; the Second Affiliated Hospital of Fujian medical University: No 2020-339; The Affiliated hospital of Yangzhou University: No 2020-153. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The data that support the finds of this study are available from the corresponding author on reasonable request.

Correction To: Predictors of Poor Outcome after Endovascular Treatment for Acute Vertebrobasilar Occlusion: Data from ANGEL‑ACT Registry

Incidence and Predictors of Futile Recanalisation after Endovascular Therapy in Acute Vertebrobasilar Artery Occlusion Patients: Insight from the ANGEL-ACT Registry

The Safety and Efficacy of Endovascular Treatment in Acute Ischemic Stroke Patients Caused by Large-Vessel Occlusion with Different Etiologies of Stroke: Data from ANGEL-ACT Registry

Endovascular treatment for acute basilar artery occlusion due to different stroke etiologies of large artery atherosclerosis and cardioembolism.

Predictors of Mortality for Acute Vertebrobasilar Artery Occlusion Receiving Endovascular Treatment

Predictors and prognosis of early neurological outcomes on patients with Vertebrobasilar artery occlusion undergoing endovascular treatment

Prognostic factors for acute vertebrobasilar artery occlusion-reperfusion: a multicenter retrospective cohort study

Prognosis of acute tandem vertebrobasilar artery occlusion after endovascular revascularization:report of 647 cases

Predictors of good outcome s and mortality after thrombectomy for basilar artery occlusion within 12 hours of onset

Long-term outcome of endovascular therapy for acute basilar artery occlusion

Predicting Prolonged Mechanical Ventilation after Endovascular Treatment for Acute Vertebrobasilar Artery Occlusion

Unexplained early neurological deterioration after endovascular treatment for acute large vessel occlusion: incidence, predictors, and clinical impact: Data from ANGEL-ACT registry

Early Neurological Deterioration Despite Recanalization in Basilar Artery Occlusion Treated by Endovascular Therapy

Effects of Admission Systemic Inflammatory Indicators on Clinical Outcomes in Patients with Vertebrobasilar Artery Occlusion: Insight from the PERSIST Registry.

General Anesthesia Vs. Non-General Anesthesia for Vertebrobasilar Stroke Endovascular Therapy

Nomogram Model of Functional Outcome for Endovascular Treatment in Patients with Acute Basilar Artery Occlusion.

The Safety and Effectiveness of Endovascular Treatment for Patients with Vertebrobasilar Artery Occlusions: According to the BEST and BASICS Criteria

Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion

Effect of vertebrobasilar dolichoectasia on endovascular therapy in acute posterior circulation infarction

Outcomes of Endovascular Therapy in Acute Basilar Artery Occlusion With Severe Symptoms

Endovascular treatment effect in vertebrobasilar artery occlusion patients with posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) <6